Biotest AG
ISIN: DE0005227235 | Ticker: BIO3 | LEI: 529900JVX7RPXBLYUD89
Country: Germany
Biotest is a global company that supplies plasma protein products and biotherapeutic drugs. Our products are primarily used in the therapeutic areas of clinical immunology, haematology and intensive care medicine. For patients with serious and often chronic diseases they provide targeted treatment, which generally enable them to lead almost normal lives.
Within our areas of specialisation, we start from pre-clinical and clinical development to manufacturing and global marketing. Research, development and production are carried out at our main headquarters in Germany. Our own sales organisations (subsidiaries) and cooperating partners represent our global distribution network.
1946
Served areaWorldwide
Headcount1,663
HeadquartersLandsteinerstraße 5, 63303 Dreieich – Germany
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 29.11.21 | Bernöster, Dr. Katrin | Other | Sell | EUR 15,640.00 |
| 29.11.21 | Realsoul Holding S.A. | Close relation | Buy | EUR 1,713.60 |
| 18.11.21 | Fleck, Stephan | Other | Sell | EUR 120,870.00 |
| 18.11.21 | Schüttrumpf, Dr. Jörg | Other | Sell | EUR 99,895.50 |
| 18.11.21 | Reinecke, Dr. Martin | Other | Sell | EUR 37,715.00 |
| 18.11.21 | Moritz, Michael | Other | Sell | EUR 35,460.00 |
DE0005227235
LEI529900JVX7RPXBLYUD89
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.